S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Perceptive Advisors/Q1 2023

Perceptive Advisors

Period: Q1 2023 Β· Filed: 2023-05-16
View on SEC EDGAR β†—
AUM
$3.39B
Total portfolio value
Positions
99
Reported securities
Top Holding
FOLD
9.1% $306.8M
QoQ Changes
+0 / -0
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-05-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
FOLDAMICUS THERAPEUTICS INC$306.8M9.06%β€”β€”
9.1%
RETAREATA PHARMACEUTICALS INC$197.2M5.82%β€”β€”
5.8%
AMLXAMYLYX PHARMACEUTICALS INC$177.1M5.23%$29.34$18.27-37.7%
5.2%
CERECEREVEL THERAPEUTICS HLDNG I$158.8M4.69%β€”β€”
4.7%
MDGLMADRIGAL PHARMACEUTICALS INC$157.6M4.65%$242.26$528.10+118.0%
4.7%
RXDXPROMETHEUS BIOSCIENCES INC$136.6M4.03%β€”β€”
4.0%
ACLXARCELLX INC$118.4M3.49%$30.81β€”
3.5%
LIANYLIANBIO$112.8M3.33%$0.00$0.12
3.3%
ALDXALDEYRA THERAPEUTICS INC$112.7M3.33%$9.93$2.27-77.1%
3.3%
IOVAIOVANCE BIOTHERAPEUTICS INC$93.7M2.77%$6.11$4.31-29.5%
2.8%
INBXINHIBRX INC$68.2M2.01%β€”$97.58
2.0%
XENEXENON PHARMACEUTICALS INC$65.6M1.94%$35.79$60.96+70.3%
1.9%
BMRNBIOMARIN PHARMACEUTICAL INC$65.5M1.93%$97.24$58.99-39.3%
1.9%
TMCITREACE MED CONCEPTS INC$61.5M1.82%$25.19$4.21-83.3%
1.8%
NUVLNUVALENT INC$60.0M1.77%$26.09$123.73+374.2%
1.8%
MRTXMIRATI THERAPEUTICS INC$58.5M1.73%β€”β€”
1.7%
CRNXCRINETICS PHARMACEUTICALS IN$57.1M1.69%$16.06$42.23+162.9%
1.7%
VRNAVERONA PHARMA PLC$54.9M1.62%β€”β€”
1.6%
SWTXSPRINGWORKS THERAPEUTICS INC$53.5M1.58%β€”β€”
1.6%
OBIOORCHESTRA BIOMED HLDGS INC$44.6M1.32%$19.57$4.19-78.6%
1.3%
VRDNVIRIDIAN THERAPEUTICS INC$44.2M1.30%$25.44$19.40-23.7%
1.3%
PCVXVAXCYTE INC$43.9M1.29%$37.48$58.39+55.8%
1.3%
RAPTRAPT THERAPEUTICS INC$42.0M1.24%β€”β€”
1.2%
SNYSANOFI$41.8M1.23%$45.65$43.16-5.5%
1.2%
ADMAADMA BIOLOGICS INC$39.4M1.16%$3.31$8.95+170.4%
1.2%
NTRANATERA INC$39.3M1.16%$55.52$279.32+403.1%
1.2%
ACRVACRIVON THERAPEUTICS INC$38.2M1.13%$12.69$1.72-86.5%
1.1%
APLSAPELLIS PHARMACEUTICALS INC$36.6M1.08%$65.96β€”
1.1%
MGTXMEIRAGTX HLDGS PLC$36.0M1.06%$5.17$13.92+169.3%
1.1%
SRPTSAREPTA THERAPEUTICS INC$36.0M1.06%$137.83$19.28-86.0%
1.1%

Quarter-on-Quarter Activity

New Positions

None this quarter

Exited Positions

None this quarter

Increased

None this quarter

Trimmed

None this quarter

← Back to Hedge Funds